INR and PT: reading the number and acting on it

What the test measures

Prothrombin time, PT, measures how many seconds it takes plasma to clot after a tissue factor reagent is added, reflecting the extrinsic and common coagulation pathways: factors I, II, V, VII, and X. Because different labs use different reagents, raw PT seconds vary from one lab to another.

INR, the international normalized ratio, corrects for that variability by standardizing PT against a reference reagent sensitivity, the ISI. INR is the number clinicians actually use to titrate warfarin because it is comparable across labs and over time, which raw PT is not.

Normal ranges and what moves them

A normal PT is roughly 11 to 13.5 seconds, and a normal INR for someone not on anticoagulants is close to 1.0. Warfarin extends both values by inhibiting vitamin K-dependent clotting factors, II, VII, IX, and X, and the therapeutic INR range is set by indication rather than a single universal target.

Liver disease lowers production of clotting factors and raises both PT and INR independent of any medication. Vitamin K deficiency, malabsorption, and a diet with a sudden large increase in leafy greens can shift INR in the opposite direction on a stable warfarin dose, because vitamin K intake and warfarin effect are directly linked.

What a high result means

A high INR means blood is taking longer to clot than the target, so the bleeding risk rises as the number climbs. An INR of 4 to 5 without bleeding is usually managed by holding a dose or two and rechecking; above 5 without bleeding, expect the dose held and possibly a small oral dose of vitamin K, per protocol.

An INR above 9, or any INR with active bleeding regardless of the number, is a different situation: this needs prompt provider notification, and the patient may need vitamin K, fresh frozen plasma, or a prothrombin complex concentrate depending on the severity of bleeding and the clinical picture.

What a low result means

A low or subtherapeutic INR on warfarin, below the target range, means the patient is not adequately anticoagulated and is at increased risk for the clot the medication was meant to prevent: stroke in atrial fibrillation, valve thrombosis with a mechanical valve, or recurrent venous thromboembolism.

A subtherapeutic INR is common early in warfarin therapy, since it can take several days of dosing to reach a stable target, and bridging with a fast-acting anticoagulant such as heparin or enoxaparin is standard practice until the INR is therapeutic. Missed doses, a diet suddenly rich in vitamin K, or interacting medications are the usual causes once a patient has been stable.

Nursing actions by result

For any warfarin patient, check the INR before administering the dose and hold the dose and notify the provider if the result is out of range, high or low, per the facility protocol or a specific hold parameter. Assess for bleeding at every shift: gums, stool color, bruising, hematuria, and any new headache.

For an INR above 5 without bleeding, expect the dose held and the provider notified; vitamin K may be ordered depending on the exact value and bleeding risk profile. For an INR above 9 or any active bleeding, this is urgent: notify the provider immediately, anticipate an order for vitamin K and possibly fresh frozen plasma or a prothrombin complex concentrate, and monitor vital signs closely.

For a subtherapeutic INR, confirm the patient is taking the medication as prescribed, ask about recent diet and any new medications, and anticipate bridging therapy with a heparin product until the INR reaches target.

Patient preparation and teaching

No fasting is required for PT or INR, and the blood draw itself needs no special preparation. Tell the patient the result guides their warfarin dose, and that dosing may change between checks, sometimes frequently at the start of therapy.

Teach the patient to keep vitamin K intake consistent day to day rather than avoiding leafy greens entirely, since a stable diet lets the dose be calibrated reliably. Warn against starting or stopping any new medication, including over-the-counter drugs and supplements, without checking with the provider, since many interact with warfarin. Reinforce the signs to report: unusual bruising, blood in urine or stool, prolonged bleeding from a cut, or a severe headache, and stress the importance of attending every scheduled INR check.